9th Circ. Won't Revisit FCA Ruling Over Drug Price Program
The Ninth Circuit has said it will not disturb its March ruling allowing a hospital chain to pursue a False Claims Act lawsuit against various pharmaceutical companies for allegedly causing the...To view the full article, register now.
Already a subscriber? Click here to view full article